🧠 Parkinson's Digest Give Feedback
  • All
  • Research
  • Trials
  • News
Priming Through Timing. Using Opposing Strategies to Enhance Motor Learning for Individuals With Parkinson's Disease
Trial N/A Completed Nov. 12, 2019
A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
Trial Phase 2 Completed Nov. 7, 2019
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Trial Phase 3 Completed Nov. 7, 2019
Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study
Trial Phase 3 Completed Nov. 6, 2019
A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
Trial Phase 2 Completed Nov. 5, 2019
Pilot Trial of Transnasal Nicotine in Parkinson Disease
Trial Phase 2 Completed Nov. 5, 2019
Diagnostic Tools for Parkinson's Disease
Trial N/A Completed Nov. 3, 2019
7T MRS in Parkinson's Disease
Trial N/A Completed Oct. 31, 2019
Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
Trial Phase 1 Completed Oct. 31, 2019
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
Trial N/A Completed Oct. 31, 2019
Functional Connectivity Parkinson Disease
Trial N/A Completed Oct. 31, 2019
Learning Effective New Strategies for Worry in Parkinson's Disease
Trial N/A Unknown Oct. 30, 2019
Video Based Mindfulness Based Stress Reduction
Trial N/A Completed Oct. 30, 2019
Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease
Trial N/A Completed Oct. 29, 2019
Trial of Probiotics for Constipation in Parkinson's Disease
Trial N/A Completed Oct. 29, 2019
Helicobacter Pylori Eradication Study in Parkinson's Disease
Trial N/A Completed Oct. 29, 2019
Patient-Centered PD Ambulatory Monitoring System
Trial N/A Unknown Oct. 28, 2019
Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
Trial Phase 1 Completed Oct. 28, 2019
Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease
Trial Phase 2 Completed Oct. 28, 2019
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
Trial Phase 3 Completed Oct. 28, 2019
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Feedback | Privacy Policy | Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest